Total Funding
45
22
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
224555
Osprey Medical develops and commercializes its propriety CINCOR™ System designed for the prevention of contrast induced mephropathy.
Neville Mitchell: Non-Executive DirectorPast Role: Cochlear, Chief Financial Officer and Company Secretary
MIKE McCORMICK: President & CEOPast Role: Anulex Technologies, President & CEO
About the Company
Osprey Medical is a medical device company incorporated in 2005 with operations based Minnetonka, Minnesota, USA. The Company is focused on the development and commercialization of its propriety CINCOR™ System designed for the prevention of Contrast Induced Nephropathy (CIN). The CINCOR™ System originated from technology developed at the Baker
Heart and Diabetes Institute in Melbourne, Australia.
